Optimising first- and second-line treatment strategies for untreated major depressive disorder — the SUN☺D study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial

[1] Abbing-Karahagopian V(2014)Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications Eur J Clin Pharmacol 70 849-857

[2] Huerta C(2015)Trends in prescription drug use among adults in the United States from 1999-2012 JAMA 314 1818-1831

[3] Souverein PC(2011)Initial prescription of antipsychotics and antidepressants in general practice and specialist care in Norway Acta Psychiatr Scand 123 459-465

[4] de Abajo F(2009)Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis Lancet 373 746-758

[5] Leufkens HG(2013)Prescription patterns following first-line new generation antidepressants for depression in Japan: a naturalistic cohort study based on a large claims database J Affect Disord 150 916-922

[6] Slattery J(2013)World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders World J Biol Psychiatry 14 334-385

[7] Alvarez Y(2010)Practice guideline for the treatment of patients with major depressive disorder (third edition) Am J Psychiatry 167 1-152

[8] Miret M(1999)Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials Br J Psychiatry 174 297-303

[9] Gil M(2015)Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine Acta Psychiatr Scand 131 408-416

[10] Oliva B(2016)A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors Transl Psychiatry 6 e834-348

[1] Abbing-Karahagopian V(2014)Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications Eur J Clin Pharmacol 70 849-857

[2] Huerta C(2015)Trends in prescription drug use among adults in the United States from 1999-2012 JAMA 314 1818-1831

[3] Souverein PC(2011)Initial prescription of antipsychotics and antidepressants in general practice and specialist care in Norway Acta Psychiatr Scand 123 459-465

[4] de Abajo F(2009)Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis Lancet 373 746-758

[5] Leufkens HG(2013)Prescription patterns following first-line new generation antidepressants for depression in Japan: a naturalistic cohort study based on a large claims database J Affect Disord 150 916-922

[6] Slattery J(2013)World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders World J Biol Psychiatry 14 334-385

[7] Alvarez Y(2010)Practice guideline for the treatment of patients with major depressive disorder (third edition) Am J Psychiatry 167 1-152

[8] Miret M(1999)Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials Br J Psychiatry 174 297-303

[9] Gil M(2015)Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine Acta Psychiatr Scand 131 408-416

[10] Oliva B(2016)A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors Transl Psychiatry 6 e834-348